(Q54505734)

30 May 2018

title

Comparative effects of nifedipine, verapamil, and diltiazem on experimental pulmonary hypertension. (English)

1 reference

30 May 2018

main subject

arterial hypertension

0 references

1 reference

1 reference

T E Young

1

1 reference

30 May 2018

L J Lundquist

series ordinal

2

1 reference

30 May 2018

E Chesler

series ordinal

3

1 reference

30 May 2018

E K Weir

series ordinal

4

1 reference

30 May 2018

language of work or name

English

0 references

publication date

1 January 1983

1 reference

30 May 2018

American Journal of Cardiology

published in

1 reference

30 May 2018

volume

51

1 reference

30 May 2018

issue

1

1 reference

30 May 2018

page(s)

195-200

1 reference

30 May 2018

The hemodynamic effects of isoproterenol on pulmonary hypertension in man

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2883%2980035-6

Isoproterenol as a potential pulmonary vasodilator in primary pulmonary hypertension.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2883%2980035-6

Primary Pulmonary Hypertension Treated with Oral Phentolamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2883%2980035-6

Primary pulmonary hypertension: effects of nifedipine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2883%2980035-6

Inhibition of Hypoxic Pulmonary Vasoconstriction by Nifedipine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2883%2980035-6

Clinical and haemodynamic effects of diazoxide in primary pulmonary hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2883%2980035-6

Diazoxide in primary pulmonary hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2883%2980035-6

Oral hydralazine therapy for primary pulmonary hypertension.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2883%2980035-6

Diazoxide in treatment of primary pulmonary hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2883%2980035-6

Primary pulmonary hypertension: beneficial therapy with diltiazem

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2883%2980035-6

Comparative pharmacology of calcium antagonists: Nifedipine, verapamil and diltiazem

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2883%2980035-6

Inhibition of hypoxic pulmonary vasoconstriction by calcium antagonists in isolated rat lungs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2883%2980035-6

Reduction of bovine pulmonary hypertension by normoxia, verapamil and hexoprenaline

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2883%2980035-6

Differential effects of systemic and intracoronary calcium channel blocking agents on global and regional left ventricular function in conscious dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2883%2980035-6

"Calcium Influx Blockers" and Vascular Smooth Muscle: Do We Really Understand the Mechanisms?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2883%2980035-6

Hemodynamics and coronary flow following diltiazem administration in anesthetized dogs and in humans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2883%2980035-6

Pulmonary Hemodynamics in Primary Pulmonary Hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2883%2980035-6

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-9149(83)80035-6

1 reference

30 May 2018

1 reference

30 May 2018